FSTL1 and gastric cancer: MiR-137-3p played a tumor-suppressive role in GC, and its target gene COL5A1 could reversely sponge miR-137-3p to relieve its targeted inhibition of FSTL1, which might promote the progression of GC by affecting immune infiltration.